| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 非头孢类药品(元) | 19,210,500.95 | 38,404,182.92 | 21,342,007.61 | 50,441,853.79 | 33,857,528.24 |
| 头孢类药品(元) | 156,026,808.00 | 318,789,585.93 | 158,993,093.34 | 379,228,269.87 | 188,886,793.29 |
| 营业成本(元) | |||||
| 非头孢类药品(元) | 10,131,518.52 | 22,772,937.34 | 10,833,718.33 | 30,314,727.25 | - |
| 头孢类药品(元) | 84,238,831.97 | 187,473,656.20 | 93,765,501.06 | 180,657,536.60 | - |
| 毛利(元) | |||||
| 非头孢类药品(元) | 9,078,982.43 | 15,631,245.58 | 10,508,289.28 | 20,127,126.54 | - |
| 头孢类药品(元) | 71,787,976.03 | 131,315,929.73 | 65,227,592.28 | 198,570,733.27 | - |
| 毛利率(%) | |||||
| 非头孢类药品(%) | 47.26 | 40.70 | 49.24 | 39.90 | - |
| 头孢类药品(%) | 46.01 | 41.19 | 41.03 | 52.36 | - |
| 收入构成(%) | |||||
| 非头孢类药品(%) | 10.96 | 10.75 | 11.83 | 11.74 | 15.20 |
| 头孢类药品(%) | 89.04 | 89.25 | 88.17 | 88.26 | 84.80 |
| 毛利构成(%) | |||||
| 非头孢类药品(%) | 11.23 | 10.64 | 13.87 | 9.20 | - |
| 头孢类药品(%) | 88.77 | 89.36 | 86.13 | 90.80 | - |